Introduction：Basic information about CAS 892553-42-3|Etaracizumab, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Etaracizumab |
|---|
| CAS Number | 892553-42-3 | Molecular Weight | / |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | / | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
Etaracizumab BiologicalActivity
| Description | Etaracizumab (LM 609) is an αvβ3 integrin IgG1 monoclonal antibody. Etaracizumab inhibits angiogenesis and melanoma tumor growth. Etaracizumab can be used to research anticancer[1]. |
|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Cytoskeleton >>Integrin |
|---|
| References | [1]. Hersey P, et al. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Cancer. 2010 Mar 15;116(6):1526-34. |
|---|
Chemical & Physical Properties
| No Any Chemical & Physical Properties |
